These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 6768682)
1. Oncogenicity of gibbon type-C myelogenous leukemia virus. Kawakami TG; Kollias GV; Holmberg C Int J Cancer; 1980 May; 25(5):641-6. PubMed ID: 6768682 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of captive gibbons (Hylobates spp., Nomascus spp., Symphalangus spp.) in North American Zoological Institutions for Gibbon Ape Leukemia Virus (GALV). Siegal-Willott JL; Jensen N; Kimi D; Taliaferro D; Blankenship T; Malinsky B; Murray S; Eiden MV; Xu W J Zoo Wildl Med; 2015 Mar; 46(1):27-33. PubMed ID: 25831573 [TBL] [Abstract][Full Text] [Related]
3. Isolation and identification of lymphocytic and myelogenous leukemia-specific sequences in genomes of gibbon oncornaviruses. Sun L; Kawakami TG J Virol; 1980 Aug; 35(2):400-8. PubMed ID: 6255180 [TBL] [Abstract][Full Text] [Related]
4. Antigenic characterization of a new gibbon ape leukemia virus isolate: seroepidemiologic assessment of an outbreak of gibbon leukemia. Krakower JM; Tronick SR; Gallagher RE; Gallo RC; Aaronson SA Int J Cancer; 1978 Dec; 22(6):715-20. PubMed ID: 82546 [TBL] [Abstract][Full Text] [Related]
5. A new look at the origins of gibbon ape leukemia virus. McKee J; Clark N; Shapter F; Simmons G Virus Genes; 2017 Apr; 53(2):165-172. PubMed ID: 28220345 [TBL] [Abstract][Full Text] [Related]
6. Natural antibodies in sera from healthy humans to antigens on surfaces of type C RNA viruses and cells from primates. Aoki T; Walling MJ; Bushar GS; Liu M; Hsu KC Proc Natl Acad Sci U S A; 1976 Jul; 73(7):2491-5. PubMed ID: 181753 [TBL] [Abstract][Full Text] [Related]
7. Studies on the specificity of human antibodies reacting with GP70 and P15 antigens of baboon endogenous (BaEV) and gibbon ape leukaemia (GaLV) viruses. Tóth FD; Váczi L; Szabó B; Réthy A; Rák K; Kiss J; Kiss A Acta Virol; 1984 May; 28(3):191-7. PubMed ID: 6147994 [TBL] [Abstract][Full Text] [Related]
8. Oncornavirus lytic activity in the serum of gibbon apes. Gallagher RE; Schrecker AW; Walter CA; Gallo RC J Natl Cancer Inst; 1978 Mar; 60(3):677-82. PubMed ID: 203712 [TBL] [Abstract][Full Text] [Related]
9. Natural transmission of gibbon leukemia virus. Kawakami TG; Sun L; McDowell TS J Natl Cancer Inst; 1978 Oct; 61(4):1113-5. PubMed ID: 212567 [TBL] [Abstract][Full Text] [Related]
10. Gibbon ape leukemia virus-Hall's Island: new strain of gibbon ape leukemia virus. Reitz MS; wong-Staal F; Haseltine WA; Kleid DG; Trainor CD; Gallagher RE; Gallo RC J Virol; 1979 Jan; 29(1):395-400. PubMed ID: 219232 [TBL] [Abstract][Full Text] [Related]
11. Specificity of naturally occurring antibody in normal gibbon serum. Aoki T; Liu M; Walling MJ; Bushar GS; Brandchaft PB; Kawakami TG Science; 1976 Mar; 191(4232):1180-3. PubMed ID: 1062861 [TBL] [Abstract][Full Text] [Related]
12. Antiretroviral immune response and plasma interferon in different phases of chronic granulocytic leukemia. Szabó B; Tóth FD; Kiss J; Kiss A; Rák K Leuk Res; 1993 Apr; 17(4):311-23. PubMed ID: 7683737 [TBL] [Abstract][Full Text] [Related]
13. Studies on the prevalence of type C virus associated with gibbon hematopoietic neoplasms. Kawakami TG; Buckley PM; dePaoli A; Noll W; Bustad LK Bibl Haematol; 1975; (40):385-9. PubMed ID: 51628 [TBL] [Abstract][Full Text] [Related]
14. Enhanced induction of growth of B lymphoblasts from fresh human blood by primate type-C retroviruses (gibbon ape leukemia virus and simian sarcoma virus). Markham PD; Ruscetti F; Salahuddin SZ; Gallagher RE; Gallo RC Int J Cancer; 1979 Feb; 23(2):148-56. PubMed ID: 216638 [No Abstract] [Full Text] [Related]
15. Cytotoxicity of lymphocytes and antibodies against autologous tumor cells in patients with myeloid leukemias and preleukemic disorders. I. Blocking activity of gp70 antigens of primate type C viruses. Szabó B; Tóth FD; Váczi L; Réthy A; Kiss A; Rák K Neoplasma; 1983; 30(2):129-35. PubMed ID: 6302527 [TBL] [Abstract][Full Text] [Related]
16. A notable phenomenon recapitulated. A fusion product of a murine lymphoma cell and a leukemia virus-neutralizing antibody-producer host plasma cell formed spontaneously and secreting the specific antibody continuously. Sinkovics JG Acta Microbiol Immunol Hung; 2005; 52(1):1-40. PubMed ID: 15957233 [TBL] [Abstract][Full Text] [Related]
17. Cellular and humoral cytotoxicity in patients with leukaemia and preleukaemia. II. Oncovirus specificity of the reaction. Szabó B; Tóth FD; Váczi L; Réthy A; Kiss A; Rák K Acta Microbiol Hung; 1984; 31(4):365-72. PubMed ID: 6085606 [TBL] [Abstract][Full Text] [Related]
18. Natural and experimentally induced antibodies to defined mammalian type-C virus proteins in primates. Charman HP; Kim N; White M; Marquardt H; Gilden RV; Kawakami T J Natl Cancer Inst; 1975 Dec; 55(6):1419-24. PubMed ID: 173868 [TBL] [Abstract][Full Text] [Related]
19. Detection by radioimmunoassay of antigens related to the P30 polypeptides of primate type C oncoviruses in peripheral leukocytes from patients with chronic myelogenous leukaemia. Tóth FD; Váczi L; Kiss J; Réthy A; Kiss A; Rák K Acta Virol; 1981 Nov; 25(6):376-80. PubMed ID: 6120639 [TBL] [Abstract][Full Text] [Related]
20. Virus and cell requirements for Friend virus granulocytic leukemogenesis in long-term bone marrow cultures of NIH swiss [N:NIH(S)] mice. Greenberger JS; Newburger PE; Lipton JM; Moloney WC; Sakakeeny MA; Jackson PL J Natl Cancer Inst; 1980 Apr; 64(4):867-78. PubMed ID: 6928998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]